Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 30 entries
View as:

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT06921941 Org: User:
Start: 04/08/25 End: 05/31/25 Due: 05/31/26

Study of AT-527 in Healthy and HCV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03219957 Org: User:
Start: 07/06/17 End: 06/20/18 Due: 06/20/19

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT05366439 Org: User:
Start: 04/22/22 End: 03/16/23 Due: 03/16/24

Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT05137626 Org: User:
Start: 11/03/21 End: 12/12/21 Due: 12/12/22

Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05905484 Org: User:
Start: 04/25/23 End: 05/31/23 Due: 05/31/24

Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

Phase: N/A Priority: Normal
NCT ID: NCT04784000 Org: User:
Start: 03/01/21 End: 04/10/21 Due: 04/10/22

Bronchopulmonary PK of AT-527 (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT04877769 Org: User:
Start: 04/25/21 End: 08/31/21 Due: 08/31/22

Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal

Phase: N/A Priority: Normal
NCT ID: NCT05256732 Org: User:
Start: 02/22/22 End: 08/23/22 Due: 08/23/23

Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir

Phase: N/A Priority: Normal
NCT ID: NCT05731843 Org: User:
Start: 01/30/23 End: 03/15/23 Due: 03/15/24

Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

Phase: N/A Priority: Normal
NCT ID: NCT06204679 Org: User:
Start: 12/14/23 End: 08/25/24 Due: 08/25/25

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Phase: N/A Priority: Normal
NCT ID: NCT06868264 Org: User:
Start: 04/07/25 End: 12/31/26 Due: 12/31/27

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT05004415 Org: User:
Start: 07/28/21 End: 08/12/21 Due: 08/12/22

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Phase: N/A Priority: Normal
NCT ID: NCT07037277 Org: User:
Start: 06/30/25 End: 03/31/27 Due: 03/31/28

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

Phase: N/A Priority: Normal
NCT ID: NCT07007806 Org: User:
Start: 06/30/25 End: 06/28/25 Due: 06/28/26

Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT04865445 Org: User:
Start: 04/22/21 End: 05/15/21 Due: 05/15/22

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04309734 Org: User:
Start: 10/31/21 End: 09/30/22 Due: 09/30/23

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

Phase: N/A Priority: Normal
NCT ID: NCT04396106 Org: User:
Start: 05/26/20 End: 02/28/22 Due: 02/28/23

Study of AT-752 in Patients With Dengue Infection

Phase: N/A Priority: Normal
NCT ID: NCT05466240 Org: User:
Start: 04/29/22 End: 01/19/23 Due: 01/19/24

Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

Phase: N/A Priority: Normal
NCT ID: NCT06356194 Org: User:
Start: 04/15/24 End: 05/30/24 Due: 05/30/25

Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT05154123 Org: User:
Start: 11/16/21 End: 12/23/21 Due: 12/23/22

Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT04849299 Org: User:
Start: 04/18/21 End: 05/10/21 Due: 05/10/22

Study of AT-752 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04722627 Org: User:
Start: 03/09/21 End: 11/14/21 Due: 11/14/22

The Study of Bemnifosbuvir in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05905497 Org: User:
Start: 04/26/23 End: 05/19/23 Due: 05/19/24

Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05724693 Org: User:
Start: 01/30/23 End: 04/23/24 Due: 04/23/25

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects with Chronic HCV

Phase: N/A Priority: Normal
NCT ID: NCT05904470 Org: User:
Start: 05/30/23 End: 01/28/25 Due: 01/28/26